Drugmaker Organon fully exempted West Virginia providers from its contract pharmacy policy and loosened its restrictions in three additional states.

Organon Ends or Loosens 340B Contract Pharmacy Restrictions in Four More States

Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.